TP53 and neoplasm: As positive TP53 IHC correlates with aggressive tumor characteristics that often indicate adjuvant chemotherapy treatment in the clinic, some SNPs observed to interact with TP53 IHC in our pilot study may reflect response to treatment rather than a true biological interaction with TP53.